These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2340205)

  • 1. Psoralen/UV inactivation of HIV-1-infected cells for use in cytologic and immunologic procedures.
    Watson AJ; Klaniecki J; Hanson CV
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):503-13. PubMed ID: 2340205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice.
    Morrey JD; Bourn SM; Bunch TD; Jackson MK; Sidwell RW; Barrows LR; Daynes RA; Rosen CA
    J Virol; 1991 Sep; 65(9):5045-51. PubMed ID: 1908029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells.
    Redfield DC; Richman DD; Oxman MN; Kronenberg LH
    Infect Immun; 1981 Jun; 32(3):1216-26. PubMed ID: 6265375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair of psoralen plus near ultraviolet light damage in bacteriophage T4.
    Zerler BR; Wallace SS
    Photochem Photobiol; 1979 Sep; 30(3):413-6. PubMed ID: 390566
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo.
    Margolis-Nunno H; Bardossy L; Robinson R; Ben-Hur E; Horowitz B; Blajchman MA
    Transfusion; 1997 Sep; 37(9):889-95. PubMed ID: 9308633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and purification of psoralen and isopsoralen and their efficacy and safety in the treatment of osteosarcoma in nude rats.
    Lu H; Zhang L; Liu D; Tang P; Song F
    Afr Health Sci; 2014 Sep; 14(3):641-7. PubMed ID: 25352883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the human immunodeficiency virus type 1 (HIV-1) by ultraviolet and X irradiation.
    Henderson EE; Tudor G; Yang JY
    Radiat Res; 1992 Aug; 131(2):169-76. PubMed ID: 1379369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse effects of three furocoumarins on human lymphocyte proliferation.
    Arslan P; Cantini M; Cossarizza A; Franceschi C; Dall'Acqua F
    Life Sci; 1989; 44(26):2097-104. PubMed ID: 2747417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemical inactivation of DNA and RNA viruses by psoralen derivatives.
    Hanson CV; Riggs JL; Lennette EH
    J Gen Virol; 1978 Aug; 40(2):345-58. PubMed ID: 211184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen-DNA crosslink repair in human lymphocytes. Comparison of alkaline elution with electron microscopy.
    Bohr V; Nielsen PE
    Biochim Biophys Acta; 1984 Nov; 783(2):183-6. PubMed ID: 6498201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activity of four furocoumarins: angelicin, 4,5'-dimethyl-angelicin, psoralen and 8-methyl-psoralen on V79 Chinese hamster cells.
    Babudri N; Pani B; Venturini S; Monti-Bragadin C
    J Environ Pathol Toxicol Oncol; 1986; 7(1-2):123-9. PubMed ID: 3540276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoralen: a narrative review of current and future therapeutic uses.
    Galiatsatos P; Maydan DD; Macalpine E; Schleupner B; Aitchison AH; Lerner AD; Levy B; Halthore A; Eward W
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):130. PubMed ID: 38489072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structure of a psoralen-thymine photoproduct: model for the interaction with DNA on the pyrone ring of psoralen].
    Salahou PA; Courseille C; Decout JL; Lhomme J
    Acta Crystallogr C; 1988 Dec; 44 ( Pt 12)():2167-70. PubMed ID: 3270556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disinfection of cell-associated and extracellular HIV-1 by PUVA treatment.
    Deichmann M; Sczakiel G; Haas R
    J Virol Methods; 1997 Oct; 68(1):89-95. PubMed ID: 9395143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-Ray Psoralen Activated Cancer Therapy (X-PACT).
    Oldham M; Yoon P; Fathi Z; Beyer WF; Adamson J; Liu L; Alcorta D; Xia W; Osada T; Liu C; Yang XY; Dodd RD; Herndon JE; Meng B; Kirsch DG; Lyerly HK; Dewhirst MW; Fecci P; Walder H; Spector NL
    PLoS One; 2016; 11(9):e0162078. PubMed ID: 27583569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage nucleoprotein-psoralen interaction: quantitative characterization of dark and photoreactions.
    Rontó G; Tóth K; Gáspár S; Csik G
    J Photochem Photobiol B; 1992 Jan; 12(1):9-27. PubMed ID: 1542090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of psoralen on replicon size and mean rate of DNA synthesis in partially synchronized cells of Pisum sativum L.
    Francis D; Davies ND; Bryant JA; Hughes SG; Sibson DR; Fitchett PN
    Exp Cell Res; 1985 Jun; 158(2):500-8. PubMed ID: 4007063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralen Derivatives: Recent Advances of Synthetic Strategy and Pharmacological Properties.
    Jamalis J; Yusof FSM; Chander S; Wahab RA; P Bhagwat D; Sankaranarayanan M; Almalki F; Hadda TB
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):222-239. PubMed ID: 31241020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of psoralen-functionalized nanoscintillators against cancer cells upon X-ray excitation.
    Scaffidi JP; Gregas MK; Lauly B; Zhang Y; Vo-Dinh T
    ACS Nano; 2011 Jun; 5(6):4679-87. PubMed ID: 21553850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of the eyes against damage by light activated psoralen.
    Peek R; Swarbrick P; Stevenson R; Paver K
    Med J Aust; 1979 Feb; 1(4):113-4. PubMed ID: 431454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.